![Arvind Kush](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Arvind Kush
Directeur/Membre du Conseil chez
INHIBIKASE THERAPEUTICS, INC.
Fortune : 294 350 $ au 30/06/2026
Profil
Arvind Kush is currently an Independent Director at Inhibikase Therapeutics, Inc. since 2024 and Chief Financial & Business Officer at Candid Therapeutics, Inc. since 2014.
Formerly, Mr. Kush was Chief Financial & Accounting Officer at Rayzebio, Inc. from 2021 to 2024 and Managing Director-Healthcare Group at BofA Securities, Inc. from 2018 to 2021.
Education includes an undergraduate degree from Visvesvaraya Technological University and an MBA from Goizueta Business School-Emory.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 26/06/2026 | 145 000 ( 0,11% ) | 294 350 $ | 30/06/2026 |
Postes actifs de Arvind Kush
| Sociétés | Poste | Début |
|---|---|---|
| INHIBIKASE THERAPEUTICS, INC. | Directeur/Membre du Conseil | 21/10/2024 |
Anciens postes connus de Arvind Kush
| Sociétés | Poste | Fin |
|---|---|---|
| RAYZEBIO, INC. | Directeur Financier/CFO | 26/02/2024 |
BofA Securities, Inc.
 BofA Securities, Inc. Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | 01/11/2021 |
Formation de Arvind Kush
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
5
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Visvesvaraya Technological University
 Visvesvaraya Technological University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Goizueta Business School-Emory
 Goizueta Business School-Emory Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Inhibikase Therapeutics, Inc.
 Inhibikase Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes small-molecule kinase inhibitor therapeutics for neurological diseases | Health Technology |
BofA Securities, Inc.
BofA Securities, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Rayzebio, Inc.
 Rayzebio, Inc. Pharmaceuticals: MajorHealth Technology Develops radiopharmaceutical therapeutics for cancer treatment | Health Technology |
Choisissez Zonebourse 
